Prognostic Factors for Post-Relapse Survival after ex-vivo CD34(+)-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

BACKGROUND: Allogeneic hematopoietic cell transplantation (alloHCT) for multiple myeloma (MM), with its underlying graft-versus-tumor capacity, is a potentially curative approach for high-risk patients. Relapse is the main cause of treatment failure, but predictors for post-relapse survival are not...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Gomez-Arteaga, Alexandra, Shah, Gunjan L., Baser, Raymond E, Scordo, Michael, Ruiz, Josel D., Bryant, Adam, Dahi, Parastoo B., Ghosh, Arnab, Lahoud, Oscar B, Landau, Heather J, Landgren, Ola, Shaffer, Brian C., Smith, Eric L., Koehne, Guenther, Perales, Miguel-Angel, Giralt, Sergio A., Chung, David J.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7609585/
https://ncbi.nlm.nih.gov/pubmed/32712326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.07.016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars